Gerresheimer Rejects Takeover Bid From US Packing Firm Silgan, Say Sources
Published by Global Banking & Finance Review®
Posted on April 17, 2026
2 min readLast updated: April 17, 2026
Add as preferred source on GooglePublished by Global Banking & Finance Review®
Posted on April 17, 2026
2 min readLast updated: April 17, 2026
Add as preferred source on GoogleGerresheimer has rejected a non‑binding takeover approach from U.S. packaging rival Silgan and says discussions have ceased. The German firm is instead directing its efforts toward resolving accounting irregularities and completing the sale of its U.S. subsidiary, Centor.

MUNICH, April 17 (Reuters) - German medical packaging maker Gerresheimer has rejected a takeover bid from its U.S. rival Silgan, three sources familiar with the situation told Reuters.
There are no longer any talks between the two companies, according to the sources.
Shares in Gerresheimer were down 5.4% on the news before paring losses and swinging slightly into positive territory.
One source said that Gerresheimer wants to focus for now on resolving its accounting problems and selling its U.S. subsidiary Centor.
Reuters reported in March that Silgan had signalled an interest in taking over Gerresheimer with a non-binding offer of 41 euros ($48.31) per share, more than double the current share price.
A Gerresheimer spokesperson said the company does not comment on market rumours. Silgan did not respond to a request for comment.
($1 = 0.8488 euros)
(Reporting by Alexander Huebner, Christoph Steitz and Anneli Palmen, writing by Miranda Murray and Linda Pasquini, editing by Friederike Heine and Thomas Seythal)
US-based packaging firm Silgan made a takeover bid for Gerresheimer.
Silgan made a non-binding offer of 41 euros per share for Gerresheimer.
Gerresheimer rejected the bid to focus on resolving its accounting issues and selling its US subsidiary Centor.
No, there are currently no talks ongoing between Gerresheimer and Silgan.
Explore more articles in the Finance category
